Suchergebnisse - "Cao, Fang"

PubPharm (565)

61

Shc3 facilitates breast cancer drug resistance by interacting with ErbB2 to initiate ErbB2/COX2/MDR1 axis

enthalten in: Cancer medicine | 2023

von Liu, Y. | Cao, F. | Xia, F. | +6

62

Bone marrow mesenchymal stem cells paracrine TGF-β1 to mediate the biological activity of osteoblasts in bone repair

enthalten in: Cytokine | 2023

von Zhang, X. | Wang, G. | Wang, W. | +12

63

Label-free integrated microfluidic plasmonic biosensor from vertical-cavity surface-emitting lasers for SARS-CoV-2 receptor binding domain protein detection

enthalten in: Optics express | 2023

von Jiang, W. | Ma, Z. | Cao, F. | +6

64

Face detection method and device, intelligent cosmetic mirror, electronic equipment and storage medium

enthalten in: Europäisches Patentamt | 2023

von CAO FANG

65

Predicting prostate cancer in men with PSA levels of 4-10 ng/mL : MRI-based radiomics can help junior radiologists improve the diagnostic performance

enthalten in: Scientific reports | 2023

von Zhong, J. | Shi, L. | Liu, J. | +3

66

Vertical measurements of stable nitrogen and oxygen isotope composition of fine particulate nitrate aerosol in Guangzhou city : Source apportionment and oxidation pathway

enthalten in: The Science of the total environment | 2023

von Wang, Y. | Liu, J. | Jiang, F. | +11

67

Composition Characteristics and Sources of Non-polar Organic Compounds in PM2.5 in the Background Atmosphere of Yangtze River Delta

enthalten in: Huan jing ke xue= Huanjing kexue | 2023

von Wu, C. | Cao, F. | Jia, X. | +4

68

Skull metastasis is a poor prognostic factor for prostate cancer patients with bone metastasis : a retrospective study based on a Chinese population

enthalten in: BMC urology | 2023

von Xiong, T. | Jiang, M. | Ye, X. | +5

69

Skull metastasis is a poor prognostic factor for prostate cancer patients with bone metastasis: a retrospective study based on a Chinese population

enthalten in: BMC urology | 2023

von Xiong, T. | Jiang, M. | Ye, X. | +5

70

Skull metastasis is a poor prognostic factor for prostate cancer patients with bone metastasis: a retrospective study based on a Chinese population

enthalten in: BMC urology | 2023

von Xiong, T. | Jiang, M. | Ye, X. | +5